Evidence map›Paper›PMID 32377865›Full record

ReviewPediatric nephrology (Berlin, Germany)2020

Congenital nephrotic syndrome: is early aggressive treatment needed? Yes.

Tuula Hölttä, Hannu Jalanko

Open access · hybridAbstract readReview
In one paragraph

Review in Pediatric nephrology (Berlin, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Case Report: Novel compound heterozygousFrontiers in pediatrics · 2024
    Article
  15. Article
  16. Congenital nephrotic syndrome.Journal of perinatology : official journal of the California Perinatal Association · 2021
    Review
  17. Risk factors for post-nephrectomy hypotension in pediatric patients.Pediatric nephrology (Berlin, Germany) · 2021
    Observational
  18. Use of diuretics in the neonatal period.Pediatric nephrology (Berlin, Germany) · 2021
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Tuula HölttäDepartment of Pediatric Nephrology and Transplantation, The New Children's Hospital, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. tuula.holtta@hus.fi.
Hannu JalankoDepartment of Pediatric Nephrology and Transplantation, The New Children's Hospital, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
University of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Congenital nephrotic syndrome (CNS) was primarily considered one disease entity. Hence, one treatment protocol was proposed in the beginning to all CNS patients. Today, with the help of gene diagnostics, we know that CNS is a heterogeneous group of disorders and therefore, different treatment protocols are needed. The most important gene defects causing CNS are NPHS1, NPHS2, WT1, LAMB2, and PLCE1. Before active treatment, all infants with CNS died. It was stated already in the mid-1980s that intensive medical therapy followed by kidney transplantation (KTx) should be the choice of treatment for infants with severe CNS. In Finland, early aggressive treatment protocol was adopted from the USA and further developed for treatment of children with the Finnish type of CNS. The aim of this review is to state reasons for "early aggressive treatment" including daily albumin infusions, intensified nutrition, and timely bilateral nephrectomy followed by KTx at the age of 1-2 years.

Indexed as

Kidney TransplantationNephrectomyHumansInfantInfusions, IntravenousNephrotic SyndromeNutritional SupportSerum Albumin, HumanSeverity of Illness IndexSurvival AnalysisTime-to-TreatmentTreatment OutcomeSerum Albumin, HumanAlbuminCongenital nephrotic syndromeNephrectomyNPHS1

Identifiers

PMID32377865
PMCPMC7501131
OpenAlexW3021587576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.